Evidence-based Rheumatology
The addition of adalimumab to methotrexate reduces rheumatoid arthritis activity in patients with longstanding disease
M. Cutolo
CER2205
2004 Vol.22, N°1
PI 0034, PF 0035
Evidence-based Rheumatology
Free to view
(click on article PDF icon to read the article)
